Okuda K, Tatematsu T, Yano M, Nakamae K, Yamada T, Kasugai T, Nishida T, Sano M, Moriyama S, Haneda H, Kawano O, Sakane T, Oda R, Watanabe T, Nakanishi R. The relationship between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase, excision repair cross-complementation group 1 and class III β-tubulin, and the therapeutic effect of S-1 or carboplatin plus paclitaxel in non-small-cell lung cancer. Mol Clin Oncol. 2018 Jul;9(1):21-29.

Okuda K, Haneda H, Yokota K, Tatematsu T, Sakane T, Oda R, Watanabe T, Nakanishi R. Thymothymectomy with pulmonary partial resection using the subxiphoid approach: how to do it? Surg Today. 2018 Jun 22. doi: 10.1007/s00595-018-1686-z. [Epub ahead of print]

Watanabe T, Okuda K, Murase T, Moriyama S, Haneda H, Kawano O, Yokota K, Sakane T, Oda R, Inagaki H, Nakanishi R. Four immunohistochemical assays to measure the PD-L1 expression in malignant pleural mesothelioma. Oncotarget. 2018 Apr 17;9(29):20769-20780.

Sakane T, Murase T, Okuda K, Takino H, Masaki A, Oda R, Watanabe T, Kawano O, Haneda H, Moriyama S, Saito Y, Yamada T, Nakanishi R, Inagaki H. A comparative study of PD-L1 immunohistochemical assays with four reliable antibodies in thymic carcinoma. Oncotarget. 2018 Jan 8;9(6):6993-7009.

Okuda K, Yano M, Tatematsu T, Nakamae K, Yamada T, Kasugai T, Nishida T, Sano M, Moriyama S, Haneda H, Kawano O, Nakanishi R. S-1 vs. paclitaxel plus carboplatin as adjuvant chemotherapy for completely resected stage II/IIIA non-small-cell lung cancer. Mol Clin Oncol. 2018 Jan;8(1):73-79.

Okuda K, Watanabe T, Oda R, Sakane T, Kawano O, Haneda H, Moriyama S, Nakanishi R. Pulmonary inflammatory myofibroblastic tumor with TPM4-ALK translocation. J Thorac Dis. 2017 Nov;9(11):E1013-E1017.

Okuda K, Moriyama S, Haneda H, Kawano O, Sakane T, Oda R, Watanabe T, Nakanishi R. Recent advances in video-assisted transthoracic tracheal resection followed by reconstruction under non-intubated anesthesia with spontaneous breathing. J Thorac Dis. 2017 Sep;9(9):2891-2894.

Tatematsu T, Okuda K, Suzuki A, Oda R, Sakane T, Kawano O, Haneda H, Moriyama S, Sasaki H, Nakanishi R. The detectability of the pretreatment EGFR T790M mutations in lung adenocarcinoma using CAST-PCR and digital PCR. J Thorac Dis. 2017 Aug;9(8):2397-2403.

Suzuki A, Okuda K, Yano M, Oda R, Sakane T, Kawano O, Haneda H, Moriyama S, Nakanishi M, Nakanishi R. Exon 7 splicing variant of estrogen receptor α is associated with pathological invasiveness in smoking-independent lung adenocarcinoma. Oncol Lett. 2017 Jul;14(1):891-898.

Okuda K, Oda R, Suzuki A, Sakane T, Kawano O, Haneda H, Moriyama S, Nakanishi R. Clinicopathological factors influenced the prognosis of surgically resected pulmonary pleomorphic carcinoma. J Thorac Dis. 2017 May;9(5):1295-1302.

Okuda K, Oda R, Suzuki A, Tatematsu T, Haneda H, Moriyama S, Yano M, Nakanishi R. Expression of excision repair cross-complementation group 1 and class III β-tubulin in thymic carcinoma. Oncol Lett. 2017 May;13(5):3144-3150.

Okuda K, Nakanishi R. The non-intubated anesthesia for airway surgery. J Thorac Dis. 2016 Nov;8(11):3414-3419.

Yano M, Moriyama S, Haneda H, Nakanishi R. Thymectomy using the subxiphoid approach. J Thorac Cardiovasc Surg. 2016 Jul;152(1):278-9.

Okuda K, Yano M, Moriyama S, Haneda H, Tatematsu T, Suzuki A, Oda R, Nakanishi R. A case of mediastinum undifferentiated high grade pleomorphic sarcoma. Int J Clin Exp Med. 2015 Oct 15;8(10):19566-70.

Yano M, Yamada T, Uchida T, Moriyama S, Haneda H, Okuda K, Nakanishi R. The advantages of selecting cartridges with a 1.8 mm height for pulmonary stapling. Surg Today. 2016 Oct;46(10):1176-80.